Moreover, the JAK/STAT pathway regulates cellular senescence and some aging-associated alterations; indeed, the JAK1/2 inhibitor ruxolitinib alleviates age-related bone loss and adipose tissue inflammation in mice and rescues some premature aging phenotypes in progeria mouse models50,51. This evidence concerns the gene JAK1 and progeroid syndrome.